STOCK TITAN

BeOne Medicines Ltd. (ONC) Revenue by Year

ONC

BeOne Medicines Ltd. generated $5.3B in revenue in fiscal year 2025. This represents an increase of 40.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $6.1B in revenue. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters BeOne Medicines Ltd. has filed alongside them.

FY2025 annual
Revenue $5.3B
YoY +40.2%
5Y CAGR +76.8%
10Y CAGR +89.8%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ONC Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Revenue$6.1B$5.3B+40.2%$3.8B+55.0%$2.5B+73.7%$1.4B+20.4%$1.2B+280.8%$308.9M-27.9%$428.2M+116.0%$198.2M-16.8%$238.4M+22179.2%$1.1M-87.9%$8.8M-32.4%$13.0M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

ONC Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$1.7B+29.6%$1.5B+35.5%$1.5B+32.8%$1.4B+41.0%$1.3B+41.6%$1.1B+48.6%$1.1B+77.8%$1.0B+28.2%$929.2M+56.1%$751.7M+67.9%$634.4M+66.9%$781.3M+101.6%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More BeOne Medicines Ltd. financials

Frequently Asked Questions

What was BeOne Medicines Ltd.'s revenue in fiscal year 2025?

BeOne Medicines Ltd. generated $5.3B in revenue in fiscal year 2025.

How fast is BeOne Medicines Ltd.'s revenue growing?

BeOne Medicines Ltd. (ONC) revenue rose by 40.2% year over year, from $3.8B to $5.3B in fiscal year 2025.

What is BeOne Medicines Ltd.'s revenue over the last twelve months?

BeOne Medicines Ltd. (ONC) reported $6.1B in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 12 fiscal years this page covers, BeOne Medicines Ltd. (ONC) revenue went from $13.0M in fiscal year 2014 to $5.3B in fiscal year 2025.

BeOne Medicines Ltd. (ONC) reported $1.7B in revenue in Q2 2026. This represents an increase of 29.6% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what BeOne Medicines Ltd. (ONC) reported on that line in every period on record.